RxDoctor Payments Data

Nicole Strobel

Family · Philadelphia, PANPI 1477664241

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 82 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 16.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $632 and has fallen 94.5% since, to $35 in 2025.

$1,539in general payments, 2019–2025

Across 82 payments — averaging $18.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$251
  • AbbVie$225
  • Abbott$219
  • Novo Nordisk$119
  • AstraZeneca$100
  • Corcept Therapeutics$92
  • plus $533 from 14 others

What the payments were for

  • Food & beverage$1,539100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,539 in reported general payments places this provider in the 80th percentile of 4,717 family providers in Pennsylvania.

See all family providers in Pennsylvania →

Other family in Philadelphia

See the full list for Pennsylvania →

Where these figures come from

Is this you, or does something look wrong? →